CHRONIC LYMPHOCYTIC LEUKAEMIA (IN REMISSION)

CHRONIC LYMPHOCYTIC LEUKAEMIA (IN REMISSION) was reported 9 times

CHRONIC LYMPHOCYTIC LEUKAEMIA (IN REMISSION) is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
1 Gonadotropin Releasing Hormone Receptor Antagonist [EPC] 1 0.0000
2 BCL-2 Inhibitor [EPC] 1 0.0000
3 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
4 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
5 Leukocyte Growth Factor [EPC] 1 0.0000
6 Azole Antifungal [EPC] 1 0.0000
7 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
8 Expectorant [EPC] 1 0.0000
9 Osmotic Laxative [EPC] 1 0.0000
10 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
11 Kinase Inhibitor [EPC] 1 0.0000
12 Proton Pump Inhibitor [EPC] 1 0.0000
13 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000